Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies (Q36644814)

From Wikidata

Jump to navigation Jump to search

scientific article published on 3 November 2006

Language	Label	Description	Also known as
English	Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies	scientific article published on 3 November 2006

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

0 references

1 reference

Europe PubMed Central

Diagnostic accuracy of human papillomavirus testing in primary cervical screening: a systematic review and meta-analysis of non-randomized studies (English)

1 reference

Europe PubMed Central

15 August 2017

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Evangelos Paraskevaidis

6

object named as

Evangelos Paraskevaidis

1 reference

Europe PubMed Central

15 August 2017

4

object named as

Maria Kyrgiou

1 reference

Europe PubMed Central

15 August 2017

Pierre P L Martin-Hirsch

3

object named as

Pierre Martin-Hirsch

1 reference

Europe PubMed Central

15 August 2017

2

object named as

Marc Arbyn

1 reference

Europe PubMed Central

15 August 2017

George Koliopoulos

1

object named as

George Koliopoulos

1 reference

Europe PubMed Central

15 August 2017

Walter J Prendiville

5

object named as

Walter Prendiville

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

3 November 2006

1 reference

Europe PubMed Central

15 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

15 August 2017

104

1 reference

Europe PubMed Central

15 August 2017

1

1 reference

Europe PubMed Central

15 August 2017

232-246

1 reference

Europe PubMed Central

15 August 2017

Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. The National Co-ordinating Network for Cervical Screening Working Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

The causal relation between human papillomavirus and cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Re: Have We Resolved How To Triage Equivocal Cervical Cytology?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

The Combination of Estimates from Different Experiments

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Expanded cytological referral criteria for colposcopy in cervical screening: comparison with human papillomavirus testing

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Adjunctive testing for cervical cancer in low resource settings with visual inspection, HPV, and the Pap smear.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Combined Pap smear, cervicography and HPV DNA testing in the detection of cervical intraepithelial neoplasia and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Human papillomavirus testing in primary cervical screening.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

HPV testing in primary screening of older women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Human papillomavirus DNA testing for cervical cancer screening in low-resource settings

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Significance of high-risk human papillomavirus detection by polymerase chain reaction in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Management of women who test positive for high-risk types of human papillomavirus: the HART study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Accuracy of human papillomavirus testing in primary screening of cervical neoplasia: results from a multicenter study in India

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Accuracy of conventional cytology: results from a multicentre screening study in India

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Human papillomavirus testing for primary screening in women at low risk of developing cervical cancer. The Greek experience.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Evaluation of alternative methods of cervical cancer screening for resource-poor settings

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Benefits and costs of using HPV testing to screen for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Cost of screening for cancerous and precancerous lesions of the cervix.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Testing positive for human papillomavirus in routine cervical screening: examination of psychosocial impact.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Overview of the European and North American studies on HPV testing in primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

Human papillomavirus testing and conventional pap smear cytology as optional screening tools of women at different risks for cervical cancer in the countries of the former soviet union

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.053

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.YGYNO.2006.08.053

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36644814&oldid=1833806216"